Wixbio Ships 1000 Vials Custom IBH Triple Inactivated Vaccine to Iraq

By: WIXBIO  May 17, 2025 

Table of Contents

Shandong, China, May 14, 2025 — Wixbio announced the successful shipment of 1,000 500 ml vials of its triple inactivated Infectious Bronchitis (IBH) Types 4, 8, and 11 vaccine to customers in Iraq. This customized product is designed specifically for egg-breeding poultry and aims to help local farmers effectively prevent and control IBH, especially to provide efficient protection against the adenovirus strains prevalent in the region.

wixbio ships 1000 vials custom ibh triple inactivated vaccine to iraq

According to the customer’s feedback, the triple inactivated vaccine has performed very well in practice, with a very high protection rate against locally prevalent strains. This has greatly improved the health and breeding efficiency of egg-breeding poultry. This shows that Wixbio’s products not only meet the specific needs of the customers but have also been highly evaluated in the market.

Infectious bronchitis is an acute, highly contagious infectious disease caused by coronaviruses that poses a serious threat to the poultry industry, especially to egg-laying and breeding birds. By using this specially formulated triple inactivated vaccine, farmers can effectively reduce the incidence of the disease, improve egg production, and minimize economic losses.

wixbio ships 1000 vials custom ibh triple inactivated vaccine to iraq2

To ensure the vaccine’s activity and efficacy during transportation, all products are packaged and shipped according to strict cold chain management standards. This ensures that the vaccines arrive at their destination in the best possible condition, providing customers with a reliable guarantee.

This shipment further strengthens Wixbio’s relationship with its Iraqi customers and demonstrates the company’s expertise and market leadership in the global animal healthcare sector. Wixbio continues to develop high-quality animal healthcare solutions to support the global livestock industry.

Wixbio is a company specializing in the research, development, production, and marketing of veterinary drugs and animal vaccines. With advanced technology and a strict quality control system, the company provides strong support to the livestock industry worldwide. Wixbio always adheres to the customer’s needs as a guide and constantly promotes technological innovation, aiming to be the leading animal health partner in the world.

CONTACT US

Become our partner